Your browser doesn't support javascript.
loading
MEDI0382, a GLP-1 and glucagon receptor dual agonist, in obese or overweight patients with type 2 diabetes: a randomised, controlled, double-blind, ascending dose and phase 2a study.
Ambery, Philip; Parker, Victoria E; Stumvoll, Michael; Posch, Maximilian G; Heise, Tim; Plum-Moerschel, Leona; Tsai, Lan-Feng; Robertson, Darren; Jain, Meena; Petrone, Marcella; Rondinone, Cristina; Hirshberg, Boaz; Jermutus, Lutz.
Afiliación
  • Ambery P; Cardiovascular, Renal, and Metabolism, MedImmune, Cambridge, UK. Electronic address: amberyp@medImmune.com.
  • Parker VE; Cardiovascular, Renal, and Metabolism, MedImmune, Cambridge, UK.
  • Stumvoll M; University Hospital Leipzig, Leipzig, Germany.
  • Posch MG; Charité Research Organisation GmbH, Berlin, Germany.
  • Heise T; Profil, Neuss, Germany.
  • Plum-Moerschel L; Profil, Mainz, Germany.
  • Tsai LF; MedImmune, Gaithersburg, MD, USA.
  • Robertson D; Cardiovascular, Renal, and Metabolism, MedImmune, Cambridge, UK.
  • Jain M; Cardiovascular, Renal, and Metabolism, MedImmune, Cambridge, UK.
  • Petrone M; Cardiovascular, Renal, and Metabolism, MedImmune, Cambridge, UK.
  • Rondinone C; MedImmune, Gaithersburg, MD, USA.
  • Hirshberg B; MedImmune, Gaithersburg, MD, USA.
  • Jermutus L; Cardiovascular, Renal, and Metabolism, MedImmune, Cambridge, UK.
Lancet ; 391(10140): 2607-2618, 2018 06 30.
Article en En | MEDLINE | ID: mdl-29945727
Asunto(s)
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Péptidos / Pérdida de Peso / Diabetes Mellitus Tipo 2 / Péptido 1 Similar al Glucagón / Hipoglucemiantes / Obesidad Tipo de estudio: Clinical_trials / Prognostic_studies Límite: Adult / Aged / Female / Humans / Male / Middle aged Idioma: En Revista: Lancet Año: 2018 Tipo del documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Péptidos / Pérdida de Peso / Diabetes Mellitus Tipo 2 / Péptido 1 Similar al Glucagón / Hipoglucemiantes / Obesidad Tipo de estudio: Clinical_trials / Prognostic_studies Límite: Adult / Aged / Female / Humans / Male / Middle aged Idioma: En Revista: Lancet Año: 2018 Tipo del documento: Article